Ads
related to: combination drugs for hiv patients definition biology images of men- Treatment Costs & Savings
See If You Are Eligible For Savings
Or Assistance Programs.
- Helpful Resources
Learn About An HIV Treatment
And Discover More About Dosing.
- Helpful Patient Tools
Find Information For Patients Here.
Visit The Official Patient Website.
- HIV Treatment Injectable
Learn About A Treatment Option
And Find More Info Online Today.
- Important Safety Info
Learn About Possible Side Effects
And View Important Safety Info.
- Get Treatment Resources
See Tools Specifically For Patients
About Dosing, Savings And More.
- Treatment Costs & Savings
Search results
Results From The WOW.Com Content Network
Antiretroviral drugs are used to manage HIV/AIDS. Multiple antiretroviral drugs are often combined into a single pill in order to reduce pill burden. Some of these combinations are complete single-tablet regimens; the others must be combined with additional pills to make a treatment regimen.
Schematic description of the mechanism of the four classes of available antiretroviral drugs against HIV. There are six classes of drugs, which are usually used in combination, to treat HIV infection. Antiretroviral (ARV) drugs are broadly classified by the phase of the retrovirus life-cycle that the drug inhibits. Typical combinations include ...
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) of HIV-1. Tenofovir is a nucleotide reverse transcriptase inhibitor of HIV-1, and it can be classified as an NtRTI. These three drugs work in combination to target the HIV reverse transcriptase protein in three ways, which reduces the virus's capacity to mutate. [5]
This combination of drugs is also known to increase HIV resistance to these medications when used as pre-exposure prophylaxis (PrEP) in individuals who have already (recently) been infected with HIV. Cabotegravir ( Apretude ) shares a similar black box warning to only use the medication if a person tests negative for HIV infection.
Raltegravir (Isentress), developed by Merck & Co., was the first INSTI approved by the FDA in October 2007.; Elvitegravir (Vitekta), licensed by Gilead Sciences from Japan Tobacco, was approved by the U.S. Food and Drug Administration in August 2012, for use in adults starting HIV treatment for the first time as part of the fixed dose combination with emtricitabine and tenofovir disoproxil ...
The drug was co-developed by Gilead Sciences and Johnson & Johnson's Tibotec division and was approved by the US Food and Drug Administration (FDA) in August 2011, and by the European Medicines Agency in November 2011, [3] [5] for patients who have not previously been treated for HIV. [6]
Ads
related to: combination drugs for hiv patients definition biology images of men